Running low on cash, Marina Biotech cuts 90% of staff

Marina Biotech, a Bothell biotechnology company, said today that it has cut about 90 percent of its staff and ceased most day-to-day operations because it does not have funding to pursue its business model. “To conserve available cash, management has implemented a furlough of approximately 90% of its employees and ceased most day-to-day operations, including… Read More